Literature DB >> 7945256

Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum.

M J Rogers1, X Ji, R G Russell, G M Blackburn, M P Williamson, A V Bayless, F H Ebetino, D J Watts.   

Abstract

Bisphosphonates are a class of synthetic pyrophosphate analogues. Some are known to be potent inhibitors of osteoclast-mediated bone resorption in vivo, but their mechanisms of action are unclear. The order of potency of bisphosphonates as inhibitors of bone resorption closely matches the order of potency as inhibitors of growth of amoebae of the slime mould Dictyostelium discoideum, indicating that bisphosphonates may have a mechanism of action that is similar in both osteoclasts and Dictyostelium. Methylenebisphosphonate and several halogenated derivatives, which have low potency as antiresorptive agents and as growth inhibitors of Dictyostelium, are metabolized intracellularly by Dictyostelium amoebae into methylene-containing adenine nucleotides. We have used a combination of n.m.r. and f.p.l.c. analysis to determine whether incorporation into nucleotides is a feature of other bisphosphonates, especially those that are potent antiresorptive agents. Only bisphosphonates with short side chains or of low potency are incorporated into adenine nucleotides, whereas those with long side chains or of high potency are not metabolized. Bisphosphonate metabolism in cell-free extracts of Dictyostelium was accompanied by inhibition of aminoacylation of tRNA by several aminoacyl-tRNA synthetases. These enzymes were barely affected by the bisphosphonates that were not metabolized. The results indicate that some bisphosphonates are not metabolically inert analogues of pyrophosphate and appear to be metabolized by aminoacyl-tRNA synthetases. The cellular effects of some bisphosphonates may be the result of their incorporation into adenine nucleotides or inhibition of aminoacyl-tRNA synthetases, although the potent bisphosphonates appear to act by a different mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945256      PMCID: PMC1137591          DOI: 10.1042/bj3030303

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  The alteration of osteoclast morphology by diphosphonates in bone organ culture.

Authors:  E J Rowe; E Hausmann
Journal:  Calcif Tissue Res       Date:  1976-04-13

2.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Authors:  A Carano; S L Teitelbaum; J D Konsek; P H Schlesinger; H C Blair
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.

Authors:  S H Ralston; S J Gallacher; U Patel; F J Dryburgh; W D Fraser; R A Cowan; I T Boyle
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

4.  Growth of myxameobae of the cellular slime mould Dictyostelium discoideum in axenic culture.

Authors:  D J Watts; J M Ashworth
Journal:  Biochem J       Date:  1970-09       Impact factor: 3.857

5.  Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.

Authors:  M J Rogers; D J Watts; R G Russell; X Ji; X Xiong; G M Blackburn; A V Bayless; F H Ebetino
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

6.  Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.

Authors:  D Amin; S A Cornell; S K Gustafson; S J Needle; J W Ullrich; G E Bilder; M H Perrone
Journal:  J Lipid Res       Date:  1992-11       Impact factor: 5.922

7.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

Authors:  P M Boonekamp; L J van der Wee-Pals; M M van Wijk-van Lennep; C W Thesing; O L Bijvoet
Journal:  Bone Miner       Date:  1986-02

8.  Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages.

Authors:  M G Cecchini; R Felix; H Fleisch; P H Cooper
Journal:  J Bone Miner Res       Date:  1987-04       Impact factor: 6.741

Review 9.  Diphosphonates: history and mechanisms of action.

Authors:  H Fleisch
Journal:  Metab Bone Dis Relat Res       Date:  1981

10.  The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.

Authors:  S Adami; G P Bolzicco; A Rizzo; G Salvagno; F Bertoldo; M Rossini; R Suppi; V Lo Cascio
Journal:  Bone Miner       Date:  1987-08
View more
  11 in total

1.  The cellular uptake and metabolism of clodronate in RAW 264 macrophages.

Authors:  H Mönkkönen; M J Rogers; N Makkonen; S Niva; S Auriola; J Mönkkönen
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 2.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015

3.  Bisphosphonamidate clodronate prodrug exhibits potent anticancer activity in non-small-cell lung cancer cells.

Authors:  Marie R Webster; Ming Zhao; Michelle A Rudek; Christine L Hann; Caren L Freel Meyers
Journal:  J Med Chem       Date:  2011-09-09       Impact factor: 7.446

4.  Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonate drugs is dependent on cellular uptake.

Authors:  M J Rogers; X Xiong; X Ji; J Mönkkönen; R G Russell; M P Williamson; F H Ebetino; D J Watts
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

5.  Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner.

Authors:  Raffaella Recenti; Giuseppe Leone; Lisa Simi; Marco Orfei; Pamela Pinzani; Giuseppe Pieraccini; Gloriano Moneti; Anna Maria Carossino; Alessandro Franchi; Gianluca Bartolucci; Silvia Carbonell Sala; Mauro Ginanneschi; Annalisa Tanini; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

Review 6.  γδ T cell receptor ligands and modes of antigen recognition.

Authors:  Eric Champagne
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-02-06       Impact factor: 4.291

Review 7.  Bisphosphonate treatment of bone disease.

Authors:  N J Shaw; N J Bishop
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

Review 8.  Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Authors:  R G G Russell; N B Watts; F H Ebetino; M J Rogers
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

Review 9.  Drugs in development: bisphosphonates and metalloproteinase inhibitors.

Authors:  Jon B Catterall; Tim E Cawston
Journal:  Arthritis Res Ther       Date:  2002-11-08       Impact factor: 5.156

10.  Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation.

Authors:  Sherry S Agabiti; Jin Li; Andrew J Wiemer
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.